Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Achalasia
Interventions
DRUG

Olinciguat

oral tablet

DRUG

Matching Placebo

oral tablet

Trial Locations (5)

37232

Vanderbilt University Medical Center, Nashville

55905

Mayo Clinic, Rochester

63110

Washington University in St. Louis - School of Medicine, St Louis

84132

University of Utah School of Medicine, Division of Gastroenterology, Hepatology & Nutrition, Salt Lake City

06010

Connecticut Clinical Research Foundation, Gastroenterology Institute, Bristol

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY